Rates and Durability of Response to Salvage Radiation Therapy Among Patients With Refractory or Relapsed Aggressive Non-Hodgkin Lymphoma
- 1 January 2015
- journal article
- Published by Elsevier BV in International Journal of Radiation Oncology*Biology*Physics
- Vol. 91 (1), 223-231
- https://doi.org/10.1016/j.ijrobp.2014.09.041
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Phase 1 Study of Radiosensitization Using Bortezomib in Patients with Relapsed Non-Hodgkin's Lymphoma Receiving RadioimmunotherapyBlood, 2012
- Relapsed/Refractory Diffuse Large B-Cell LymphomaHematology-American Society Hematology Education Program, 2011
- Reduced dose radiotherapy for local control in non-Hodgkin lymphoma: A randomised phase III trialRadiotherapy and Oncology, 2011
- In Vitro Evaluation of Radioprotective and Radiosensitizing Effects of RituximabJournal of Nuclear Medicine, 2008
- Revised Response Criteria for Malignant LymphomaJournal of Clinical Oncology, 2007
- Outcome of hyperfractionated radiotherapy in chemotherapy-resistant non-Hodgkin’s lymphomaInternational Journal of Radiation Oncology*Biology*Physics, 2005
- Phase II study of concomitant chemoradiotherapy in bulky refractory or chemoresistant relapsed lymphomasInternational Journal of Radiation Oncology*Biology*Physics, 2005
- Value of radiation therapy in the management of chemoresistant intermediate grade non-Hodgkin's lymphomaRadiation Oncology Investigations, 1999
- Chemotherapy Alone Compared with Chemotherapy plus Radiotherapy for Localized Intermediate- and High-Grade Non-Hodgkin's LymphomaThe New England Journal of Medicine, 1998
- Autologous Bone Marrow Transplantation as Compared with Salvage Chemotherapy in Relapses of Chemotherapy-Sensitive Non-Hodgkin's LymphomaThe New England Journal of Medicine, 1995